4-oxo-2-nonenal has been researched along with dronabinol in 1 studies
| Studies (4-oxo-2-nonenal) | Trials (4-oxo-2-nonenal) | Recent Studies (post-2010) (4-oxo-2-nonenal) | Studies (dronabinol) | Trials (dronabinol) | Recent Studies (post-2010) (dronabinol) |
|---|---|---|---|---|---|
| 94 | 0 | 47 | 8,307 | 785 | 3,094 |
| Protein | Taxonomy | 4-oxo-2-nonenal (IC50) | dronabinol (IC50) |
|---|---|---|---|
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.218 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 0.0028 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 0.0095 | |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
1 review(s) available for 4-oxo-2-nonenal and dronabinol
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |